369 related articles for article (PubMed ID: 6278057)
41. Herpes simplex virus specified deoxypyrimidine kinase and the uptake of exogenous nucleosides by infected cells.
Jamieson AT; Subak-Shape JH
J Gen Virol; 1976 Jun; 31(3):303-14. PubMed ID: 180246
[TBL] [Abstract][Full Text] [Related]
42. Mitochondrial and herpesvirus-specific deoxypyrimidine kinases.
Leung WC; Dubbs DR; Trkula D; Kit S
J Virol; 1975 Sep; 16(3):486-97. PubMed ID: 169387
[TBL] [Abstract][Full Text] [Related]
43. Substrate specificity of feline and canine herpesvirus thymidine kinase.
Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
[TBL] [Abstract][Full Text] [Related]
44. (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
Bernaerts R; Desgranges C; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1955-61. PubMed ID: 2545207
[TBL] [Abstract][Full Text] [Related]
45. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
[TBL] [Abstract][Full Text] [Related]
46. Characterization of four herpesviruses isolated from owl monkeys and their comparison with Herpesvirus saimiri type 1 (Herpesvirus tamarinus) and herpes simplex virus type 1.
Leib DA; Hart CA; McCarthy K
J Comp Pathol; 1987 Mar; 97(2):159-69. PubMed ID: 3036914
[TBL] [Abstract][Full Text] [Related]
47. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing.
Rubsam LZ; Davidson BL; Shewach DS
Cancer Res; 1998 Sep; 58(17):3873-82. PubMed ID: 9731497
[TBL] [Abstract][Full Text] [Related]
48. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
Gustafson EA; Chillemi AC; Sage DR; Fingeroth JD
Antimicrob Agents Chemother; 1998 Nov; 42(11):2923-31. PubMed ID: 9797227
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.
Balzarini J; De Clercq E
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982
[No Abstract] [Full Text] [Related]
50. Selection of L cell sublines resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Shiraki K; Vonka V; De Clercq E; Rapp F
Intervirology; 1991; 32(4):228-33. PubMed ID: 1650764
[TBL] [Abstract][Full Text] [Related]
51. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
[TBL] [Abstract][Full Text] [Related]
52. Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine.
Harmenberg J; Wahren B; Oberg B
Intervirology; 1980; 14(5-6):239-44. PubMed ID: 6265398
[TBL] [Abstract][Full Text] [Related]
53. Thymidine kinase deletion mutants of herpes simplex virus type 1.
Sanders PG; Wilkie NM; Davison AJ
J Gen Virol; 1982 Dec; 63(2):277-95. PubMed ID: 6296278
[TBL] [Abstract][Full Text] [Related]
54. Evidence for a herpesvirus saimiri-specified DNA polymerase activity which is aphidicolin-resistant and phosphonoacetate-sensitive.
O'Hare P; Honess RW
J Gen Virol; 1983 May; 64(Pt 5):1013-24. PubMed ID: 6302206
[TBL] [Abstract][Full Text] [Related]
55. Sensitivity of viruses to phosphorylated 9-(2-hydroxyethoxymethyl)guanine revealed in TK-transformed cells.
Darby G; Larder BA; Bastow KF; Field HJ
J Gen Virol; 1980 Jun; 48(Pt 2):451-4. PubMed ID: 6249891
[TBL] [Abstract][Full Text] [Related]
56. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
[TBL] [Abstract][Full Text] [Related]
57. Importance of C-terminus of herpes simplex virus type 1 thymidine kinase for maintaining thymidine kinase and acyclovir-phosphorylation activities.
Saijo M; Suzutani T; Niikura M; Morikawa S; Kurane I
J Med Virol; 2002 Mar; 66(3):388-93. PubMed ID: 11793392
[TBL] [Abstract][Full Text] [Related]
58. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
59. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
[TBL] [Abstract][Full Text] [Related]
60. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
